missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Cell Culture Media, Supplements, and Reagents
  4. Cell Culture Reagents, Antibiotics and Supplements
  5. Antibiotics
  6. Tozasertib, MedChemExpress

Tozasertib, MedChemExpress

Product Code. 16489845
Encompass_Preferred
Click to view available options
Quantity:
50 mg
100 mg
250 mg
Unit Size:
100mg
250mg
50mg
This item is not returnable. View return policy

Product Code. 16489845

Brand: Medchem Express HY10161

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress Tozasertib (VX 680; MK-0457) is an inhibitor of Aurora A/B/C kinases with Kis of 0.6, 18, 4.6 nM, respectively.

Tozasertib (VX 680

Specifications

Chemical Name or Material Tozasertib
Physical Form Solid
CAS 639089-54-6
Color White
Quantity 250 mg
Purity Grade Notes Research
Molecular Formula C23H28N8OS
For Use With (Application) Cancer-Kinase/protease
Synonym VX 680 MK-0457
Solubility Information DMSO : ≥ 106.67 mg/mL (229.60 mM)
SMILES CC1=CC(NC2=NC(SC3=CC=C(C=C3)NC(C4CC4)=O)=NC(N5CCN(CC5)C)=C2)=NN1
Molecular Weight (g/mol) 464.59
Formula Weight 464.59
Percent Purity 98.02%
Grade Research
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.